
Conditions: Leukemia, Myeloid, Acute
Interventions: Drug: DFP-10917; Drug: Venetoclax
Sponsors: Delta-Fly Pharma, Inc.
Not yet recruiting
Conditions: Leukemia, Myeloid, Acute
Interventions: Drug: DFP-10917; Drug: Venetoclax
Sponsors: Delta-Fly Pharma, Inc.
Not yet recruiting
Mind-Body Therapy for Multiple Sclerosis Study Overview This study looked at whether Tension and Trauma Releasing Exercises (TRE) can help people with multiple sclerosis (PwMS) manage their symptoms, especially fatigue.…
Title: Practical Solutions and Value of Federated Learning Federated Learning (FL) is a cutting-edge technology that enables collaborative model training without sharing raw data, allowing organizations and individuals to work…
Safety and Efficacy of Inebilizumab for Neuromyelitis Optica Spectrum Disorder End-of-Study Results from N-MOmentum Trial In a recent study published in Lancet Neurology, the safety and efficacy of inebilizumab for…